Miguel Cantu

Assistant Professor of Pathology

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Research Cancer Research professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Miguel Cantu is an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center. His research areas encompass the differential diagnosis and genomic landscape of acute myeloid leukemia, multiple myeloma, and related myelodysplastic syndromes. He has contributed significantly to the understanding of mutation impacts on prognosis and treatment in hematologic malignancies.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Ljiljana Vasovic

Chief of Clinical Pathology

Westchester Medical Center

UNITED STATES

View details

Rashmi Kanagal Shamanna

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Beenu Thakral

Associate Professor

The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

UNITED STATES

View details

Yazan F. Madanat

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Cantu

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Differential diagnosis of multiple myeloma

TP53‐Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis

Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment

Impact of myelodysplasia‐related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype

RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis

Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group

Pancytopenia and haematopoietic precursor vacuolisation in an infant: Clues to Pearson syndrome

Updates in molecular genetics of therapy-related myeloid neoplasms

Standardized Comparison of Different DNA Sequencing Platforms.

Advances in Diagnosis of Mitochondrial Diseases: Case Report of an Infant with Pearson Syndrome

Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study

SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays

Clinical significance of blue‐green neutrophil and monocyte cytoplasmic inclusions in SARS‐CoV‐2 positive critically ill patients

Collaborators (4)

Ljiljana Vasovic

Rashmi Kanagal Shamanna

Beenu Thakral

Yazan F. Madanat

Make your next move.